002755 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Beijing Aosaikang Pharmaceutical Co., Ltd. is engages in the research, development, production and sale of drugs. Its products include decitabine, fludarabine phosphate, nedaplatin, oxaliplatin, pemetrexed disodium, palonosetron hydrochloride, topotecan hydrochloride, zoledronic acid, temozolomide, tigencycline, lansoprazole, omeprazole, and parecoxib sodium. The company was founded on December 24, 1996 and is headquartered in Nanjing, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
002755 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company